SEC 13F Intelligence

Aufman Associates Inc / MRNA

Aufman Associates Inc’s Moderna Inc Position

Does Aufman Associates Inc own Moderna Inc (MRNA)? Yes — 57.0K shares worth $3M (+1.35% of its 13F portfolio) as of Q1 2026, up from 43.2K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
57.0K
% of Portfolio
+1.35%
Quarters Held
9
currently held

Position History MRNA

Reported value by quarter
Q1 ’24: $458,208Q1 ’24Q2 ’24: $772,588Q3 ’24: $585,899Q3 ’24Q4 ’24: $460,124Q1 ’25: $462,879Q1 ’25Q2 ’25: $439,748Q3 ’25: $452,257Q3 ’25Q4 ’25: $1MQ1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202657.0K$3M+1.35%
Q4 202543.2K$1M+0.65%
Q3 202517.5K$452,257+0.25%
Q2 202516.2K$439,748+0.27%
Q1 202514.9K$462,879+0.32%
Q4 202411.1K$460,124+0.31%
Q3 20248.8K$585,899+0.38%
Q2 20246.5K$772,588+0.55%
Q1 20244.3K$458,208+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aufman Associates Inc’s full portfolio or all institutional holders of MRNA.